Research Opportunities

We want to help kidney cancer researchers locate funding opportunities. We’ll update this page with grant opportunities as we learn about them. Know of one we haven’t listed? Email us at [email protected], or tweet at us, and we’ll get it posted!

KidneyCAN is dedicated to accelerating kidney cancer research.

Our advocacy for the DoD Kidney Cancer Research Program resulted in appropriations of  $40 million in fiscal year 2020  for kidney cancer research. In 2016, this number was $0.

Our Kidney Cancer Research Summit brings translational researchers in kidney cancer together in an annual collaborative meeting. Additionally, KidneyCAN’s  “Rock the Cure” events have raised over $1,000,000 toward private research support.

The CDMRP Kidney Cancer Research Program was awarded $50 million for FY21 for kidney cancer research projects, and we are requesting the same amount for FY22.
We are reaching out to you to create the best ideas yet for your KCRP proposal this year.

Please share this notice with other researchers in your network.

Deadlines are in the August–September 2021 time frame. Now is the time to:
  • Develop your ideas
  • Build your team – even including members from other institutions
  • Gather letters of support
  • Review the grant mechanisms (including the new ones) and consider which would best support your idea
  • Consider partnerships (including industry partnerships) and collaborations

FY21 KCRP Program Announcements Released

Thank you to all of you who have chosen kidney cancer as your field for research.
As new announcements are posted we will keep you updated.
Translational Research Partnership Award
W81XWH-21-KCRP-TRPA

Close date 10/05/2021

 

Idea Development Award
W81XWH-21-KCRP-IDA

Close date 10/05/2021

 

Postdoctoral and Clinical Fellowship Award
W81XWH-21-KCRP-PCFA

Close date 10/05/2021

 

AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants

The AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants represents a joint effort to stimulate “high-risk, high-reward” research from early- to mid-career investigators. This novel grant mechanism is intended to promote and support creative, paradigm-shifting cancer research that might not be funded through conventional channels. It is expected that these grants will catalyze significant scientific discoveries that will advance our understanding of cancer and have a potentially transformative impact on future clinical practice.

The application is due on September 30, 2021.

AACR: New Funding Opportunities

We’d love to see more RCC applicants for these prestigious grant opportunities. AACR has just updated their site with this note:

We hope you and your loved ones are well, given the difficult circumstances surrounding the COVID-19 pandemic. Please note that several funding opportunities are currently under development. Although we expect that the process may likely take longer than originally expected, please know that our team is working diligently to ensure that the new grants will be launched at the earliest possible date. We are closely monitoring the situation and will post upcoming funding opportunities here once a launch date has been confirmed.
However, if you have specific questions or concerns, please feel free to contact [email protected].  

Sincerely, 

The Scientific Review and Grants Administration Team 

KidneyCAN is proud to present the 3rd Annual Kidney Cancer Research Summit on October 7 & 8, 2021. KCRS is a meeting focused on basic, translational, and clinical kidney cancer research. This meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.

The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.

Kidney cancer is the ideal sandbox for these new approaches, and without a doubt the same approach can, should and will be suitable for other cancers.

Dr. Hans Hammers, UTSW

RESEARCH UPDATES

Join Our Grassroots Army

We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...

SPRING ADVOCACY DAYS 2022 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Let’s Get Loud: Spring 2022 Advocacy Days

Let’s Get Loud: Spring 2022 Advocacy Days

On March 7-8, KidneyCAN gathered advocates from all over the United States to ask Congress for robust funding for kidney cancer research through the NIH and CDMRP (Congressionally Directed Medical Research Programs). Read on to hear about our goals for this event and how you can help fund...

Patient Resource Center

UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS

BUILDING A CARE TEAM

TREATMENT & TRIAL OPTIONS

LIVING WELL WITH KIDNEY CANCER

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

IKCC Report: Retention in Clinical Trials

IKCC Report: Retention in Clinical Trials

The International Kidney Cancer Coalition launched a pilot program to understand the barriers and other considerations that drive the decision to leave a clinical trial and uncover ways to better support patients currently in or considering joining clinical trials. Clinical trials are the key to...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Remembering Ralph: Time Well Spent

Remembering Ralph: Time Well Spent

Ralph Knapp was diagnosed in 2014 with stage IV kidney cancer and used the opportunity to increase research funding and bring hope to patients everywhere. With heavy hearts and profound sadness, we announce the passing of Ralph Knapp, a founder of KidneyCAN and leader of our mission to accelerate...